EUVIMEDEUVIMED entdecken
Open Access

Treatment outcomes and safety of concurrent chemoradiation in older adults with unresectable stage III non-small-cell lung cancer

So Jeong Kim iD, Na Young Kim, Soo Jie Chung, Changhwan Kim, Jeong-Hee Choi, In Gyu Hyun, Yohwan Yeo, Ji Young Park, Seung Hun Jang, Taehee Kim, Yun Su Sim, Chang Youl Lee und 1 weitere

Journal of Thoracic Disease · 2025-08 · 17 (8) · 5843-5855

DOI: 10.21037/jtd-2025-489 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thoracic Disease, 2025-08. Verfasst von So Jeong Kim und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong…. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Concurrent chemoradiotherapy (CCRT) is the standard treatment for patients with unresectable stage III non-small-cell lung cancer (NSCLC) and good performance status. However, there is no consensus regarding the treatment of older patients with stage III NSCLC. Therefore, this study aimed to investigate treatment outcomes and safety of CCRT in older patients with unresectable stage III NSCLC compared with those in younger patients.

Methods

We retrospectively examined all patients with unresectable stage III NSCLC treated with CCRT between 2012 and 2023 at four Korean hospitals. Progression-free survival (PFS), overall survival (OS), and adverse events (AEs) were compared between patients aged ≥70 years (older) and those aged

Schlagwörter

Stichwörter der Autor:innen

Concurrent chemoradiotherapy (CCRT)chemoradiotherapygeriatric assessmentnon-small-cell lung cancer (NSCLC)older patients

Autor:innen und Institutionen

  • Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Republic of Korea.
  • Department of Family Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Republic of Korea.
  • Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.
  • Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.
  • Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Chuncheon Sacred Heart Hospital, Chuncheon, Republic of Korea.

ORCID-Profile: So Jeong Kim

Zitieren

APA

Kim, S. J., Kim, N. Y., Chung, S. J., Kim, C., Choi, J. H., Hyun, I. G., Yeo, Y., Park, J. Y., Jang, S. H., Kim, T., Sim, Y. S., Lee, C. Y., & Kim, J. (2025). Treatment outcomes and safety of concurrent chemoradiation in older adults with unresectable stage III non-small-cell lung cancer. Journal of Thoracic Disease, 17(8), 5843-5855. https://doi.org/10.21037/jtd-2025-489

Vancouver

Kim SJ, Kim NY, Chung SJ, Kim C, Choi JH, Hyun IG, et al. Treatment outcomes and safety of concurrent chemoradiation in older adults with unresectable stage III non-small-cell lung cancer. Journal of Thoracic Disease. 2025;17(8):5843-5855. doi:10.21037/jtd-2025-489

BibTeX
@article{Kim2025,
  author = {Kim, So Jeong and Kim, Na Young and Chung, Soo Jie and Kim, Changhwan and Choi, Jeong-Hee and Hyun, In Gyu and Yeo, Yohwan and Park, Ji Young and Jang, Seung Hun and Kim, Taehee and Sim, Yun Su and Lee, Chang Youl and Kim, Junghyun},
  title = {Treatment outcomes and safety of concurrent chemoradiation in older adults with unresectable stage III non-small-cell lung cancer},
  journal = {Journal of Thoracic Disease},
  year = {2025},
  volume = {17},
  number = {8},
  pages = {5843--5855},
  doi = {10.21037/jtd-2025-489}
}
Kostenlos starten →